These differences are likely due to varying potency against bone marrow progenitor cells and the contribution of inhibiting JAK1 cytokines IL-6 and OSM to neutropenia and thrombocytopenia (71–73). This evidence concerns the gene IL6 and Decreased total neutrophil count.